新诺威 (300765)
CSPC Innovation Pharmaceutical Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 140459.29
- Circulating A-Shares(W): 140459.29
- Earnings Per Share(RMB): -0.0173
- Net Assets Per Share(RMB): 2.6255
- Operating Revenue(W RMB): 159301.41
- Total Profit(W RMB): -26557.19
- Net Profit Attributable to Parent(W RMB): -2404.89
- Net Profit Growth Rate(%): -117.26
- Weighted Return on Equity(%): -0.6500
- Operating Cash Flow Per Share(RMB): -0.1250
- Undistributed Profit Per Share(RMB): 0.8966
- Capital Reserve Per Share(RMB): 0.7005
2. Main Business
The main business covers:
- Research, development, production and sales of biopharmaceuticals
- Research, development, production and sales of functional foods and raw materials
3. Company Basic Information
- Company Name: CSPC Innovation Pharmaceutical Co., Ltd.
- Listing Date: 2019-03-22
- Industry: Food Manufacturing
- Address: No. 62 Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province
- Website: www.xnwpharma.net
- Company Profile: On February 26, 2008, Xin Nuowei Limited held a shareholders' meeting and passed a resolution to approve the overall change of Xin Nuowei Limited into a joint stock company. On March 16, 2008, all shareholders of Xin Nuowei Limited, as promoters, signed the "Sponsorship Agreement". According to the "Audit Report" (Guanghua Shenhui Zi [2008] No. 185) issued by Hebei Guanghua Certified Public Accountants Co., Ltd., Xin Nuowei Limited was converted into a joint stock company based on the audited net assets of RMB 161,236,200 as of February 29, 2008, which were converted into 150 million shares of the company, with the balance recorded as capital reserve. After the overall change to establish the joint stock company, the shareholding ratio of all original shareholders of Xin Nuowei Limited remained unchanged. On March 31, 2008, Hebei Guanghua Certified Public Accountants Co., Ltd. verified the capital contribution for this overall change to establish the joint stock company and issued the "Capital Verification Report" (Ji Guanghua Shenyan Zi [2008] No. 107). As of February 29, 2008, Xin Nuowei had received a total registered capital of RMB 150 million from all shareholders. On March 31, 2008, the Shijiazhuang Administration for Industry and Commerce approved the application for the overall change and establishment registration of the joint stock company and issued a new "Business License".
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | CSPC NBP Pharmaceutical Co., Ltd. | General Legal Person | 87953.78 | 70.53 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1778.22 | 1.43 |
| 3 | China Europe Healthcare Hybrid Securities Investment Fund Class A | Fund | 1632.25 | 1.31 |
| 4 | ICBC Credit Suisse Frontier Medical Equity Securities Investment Fund Class A | Fund | 1400.01 | 1.12 |
| 5 | ChinaAMC Innovation Pharmaceutical Theme Hybrid Securities Investment Fund Class A | Fund | 1227.70 | 0.98 |
| 6 | CSPC Ouyi Pharmaceutical Co., Ltd. | General Legal Person | 1158.72 | 0.93 |
| 7 | Huatai Youyi No.5 Hybrid Pension Product - Bank of China Limited | Asset Management Plan | 879.00 | 0.70 |
| 8 | China Securities Co., Ltd. | Broker | 805.14 | 0.65 |
| 9 | E Fund ChiNext Exchange Traded Open End Index Securities Investment Fund | Fund | 786.80 | 0.63 |
| 10 | Bank of China Innovation Medical Hybrid Securities Investment Fund Class A | Fund | 639.69 | 0.51 |
5. Concept Sectors
- Vitamins
- Innovative Drugs
- Weight Loss Drugs
- Margin Trading & Securities Lending
- Heavily Held by Brokers
- Heavily Held by Funds
- Concentrated Shareholding
- Special Loans
- Zhongchuang 100
- ChiNext Index
- SZSE 100
- SZSE 300
- Consumption 100
- Chuangye 300
- Chuangye Large Cap
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information